HEPATITIS C MEDICATION ADHERENCE OUTCOMES FOR THE LOUISIANA MEDICAID SUBSCRIPTION-BASED MODEL AT SPECIALTY PHARMACY
<div><p><b>Background:<span style="font-weight: 400;"> </b>Prior to July 2019, Hepatitis C (HCV) treatment was limited in the state of Louisiana due to restrictive prior authorization (PA) criterion for Medicaid patients.